{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:55:09Z","timestamp":1766811309123,"version":"3.48.0"},"reference-count":29,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025]]},"DOI":"10.3960\/jslrt.25045","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:06:42Z","timestamp":1761775602000},"page":"298-304","source":"Crossref","is-referenced-by-count":0,"title":["Mixed-phenotype acute leukemia with trilineage differentiation presenting as a non-leukemic mediastinal tumor"],"prefix":"10.3960","volume":"65","author":[{"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"},{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Yamato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"},{"name":"Center for Medical Education and Professional Development, Yokohama Rosai Hospital, Yokohama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Tohoku University Hospital, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Sendai, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010; 24: 1844-1851.","DOI":"10.1038\/leu.2010.202"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Weinberg OK, Seetharam M, Ren L, Alizadeh A, Arber DA. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. Am J Clin Pathol. 2014; 142: 803-808.","DOI":"10.1309\/AJCPPVUPOTUVOIB5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Charles NJ, Boyer DF. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls. Arch Pathol Lab Med. 2017; 141: 1462-1468.","DOI":"10.5858\/arpa.2017-0218-RA"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Khan M, Siddiqi R, Naqvi K. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Ann Hematol. 2018; 97: 945-953.","DOI":"10.1007\/s00277-018-3297-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Means J, Feldman D, Shaw A, Vu K. Rare Case of Mixed Phenotype Acute Leukemia Presenting as a Myeloid Sarcoma Without Leukemic Involvement. Perm J. 2022; 26: 132-136.","DOI":"10.7812\/TPP\/21.070"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ghodke K, Tembhare P, Patkar N <i>et al.<\/i> A Rare Extramedullary and Extralymphoid Presentation of Mixed Phenotypic Blastic Hematolymphoid Neoplasm: A Study of Two Cases. Indian J Med Paediatr Oncol. 2017; 38: 394-397.","DOI":"10.4103\/ijmpo.ijmpo_94_16"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2016; 96: 447-460.","DOI":"10.1111\/ejh.12722"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Coustan-Smith E, Mullighan CG, Onciu M <i>et al.<\/i> Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009; 10: 147-156.","DOI":"10.1016\/S1470-2045(08)70314-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Weinberg OK, Arber DA, How I Diagnose Acute Leukemia of Ambiguous Lineage. Am J Clin Pathol. 2022; 158: 27-34.","DOI":"10.1093\/ajcp\/aqac070"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Khoury JD, Solary E, Abla O, <i>et al.<\/i> The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022; 36: 1703-1719.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Szczepa\u0144ski T, Pongers-Willemse MJ, Langerak AW <i>et al.<\/i> Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood. 1999; 93: 4079-4085.","DOI":"10.1182\/blood.V93.12.4079"},{"key":"12","unstructured":"12 Stavroyianni N, Belessi C, Stamatopoulos K <i>et al.<\/i> Expression of recombination activating genes-1 and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literature. Haematologica. 2003; 88: 268-274."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Mi X, Griffin G, Lee W <i>et al.<\/i> Genomic and clinical characterization of B\/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Am J Hematol. 2018; 93: 1358-1367.","DOI":"10.1002\/ajh.25256"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Matutes E, Pickl WF, Van\u2019t Veer M <i>et al.<\/i> Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011; 117: 3163-3171.","DOI":"10.1182\/blood-2010-10-314682"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bayraktar UD, Barker J, Pereira D <i>et al.<\/i> An unusual presentation of extramedullary biphenotypic lymphoblastic lymphoma. Am J Hematol. 2009; 84: 616-617.","DOI":"10.1002\/ajh.21481"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Takakuwa T, Nakane T, Ohsawa M <i>et al.<\/i> The First Case of Non-leukemic Sarcoma Composed of Mixed-phenotype Acute Leukemia, B\/myeloid, Not Otherwise Specified. Intern Med. 2018; 57: 1155-1158.","DOI":"10.2169\/internalmedicine.9144-17"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Zhang ML, Sohani AR. Lymphomas of the Mediastinum and Their Differential Diagnosis. Semin Diagn Pathol. 2020; 37: 156-165.","DOI":"10.1053\/j.semdp.2020.04.005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Weinberg OK. How to think about acute leukemia of ambiguous lineage. Hematology Am Soc Hematol Educ Program. 2024; 2024: 287-292.","DOI":"10.1182\/hematology.2024000554"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 , Jelloul FZ, Nahmod KA, <i>et al<\/i><i>.<\/i> Acute lymphoblastic leukaemia with T- and B-lineage defining markers. Pathology. 2025; 57: 739-745.","DOI":"10.1016\/j.pathol.2025.01.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hashimoto M, Yamashita Y, Mori N. Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma\/leukaemias. J Pathol. 2002; 197: 341-347.","DOI":"10.1002\/path.1126"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Lai R, Juco J, Lee SF, Nahirniak S, Etches WS. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias. Am J Clin Pathol. 2000; 113: 823-830.","DOI":"10.1309\/391R-93YF-DB4D-1L35"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Shi R, Munker R. Survival of patients with mixed phenotype acute leukemias: A large population-based study. Leuk Res. 2015; 39: 606-616.","DOI":"10.1016\/j.leukres.2015.03.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Maruffi M, Sposto R, Oberley MJ, Kysh L, Orgel E. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. Leukemia. 2018; 32: 1515-1528.","DOI":"10.1038\/s41375-018-0058-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hrusak O, de Haas V, Stancikova J <i>et al.<\/i> International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018; 132: 264-276.","DOI":"10.1182\/blood-2017-12-821363"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Mishra DN, Singh G, Meher D, Jena RK, Mohanty DP. Flow Cytometric Immunophenotyping of Mixed Phenotype Acute Leukemia in a Tertiary Care Hospital of Eastern Odisha. Int J Hematol Oncol Stem Cell Res. 2025; 19: 29-36.","DOI":"10.18502\/ijhoscr.v19i1.17821"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Munker R, Brazauskas R, Wang HL <i>et al.<\/i> Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia. Biol Blood Marrow Transplant. 2016; 22: 1024-1029.","DOI":"10.1016\/j.bbmt.2016.02.013"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Munker R, Labopin M, Esteve J <i>et al.<\/i> Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT. Haematologica. 2017; 102: 2134-2140.","DOI":"10.3324\/haematol.2017.174441"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Lazzarotto D, Tanasi I, Vitale A <i>et al.<\/i> Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study. Ann Hematol. 2023; 102: 1099-1109.","DOI":"10.1007\/s00277-023-05162-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Shimizu H, Saitoh T, Machida S <i>et al.<\/i> Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis. Eur J Haematol. 2015; 95: 455-460.","DOI":"10.1111\/ejh.12516"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25045\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:41:47Z","timestamp":1766810507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25045\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25045","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25045"}}